Smart Pills Market Demonstrates a Spectacular Growth by 2028

According to Recently Published Report by The Insight Partners, “Smart Pills Market Size Report, Forecast to 2028 – COVID-19 Impact and Global Analysis – by Application, Disease Indication, and End User,” the market size is expected to grow from $4.01 billion in 2021 to $9.06 billion in 2028; it is estimated to record a CAGR of 12.3% from 2022 to 2028. Based on disease indication, the gastrointestinal diseases segment held the largest market share in 2021. However, the cancer segment is estimated to register the highest CAGR during the 2022-2028.

Get Details at: https://www.globenewswire.com/en/news-release/2023/06/28/2696370/0/en/12-3-CAGR-for-Smart-Pills-Market-Worth-9Bn-by-2028-with-Drug-Delivery-Segment-Driving-Growth-13-4-CAGR-The-Insight-Partners.html

Based on application, the global smart pills market is segmented into capsule endoscopy, drug delivery, and patient monitoring. The capsule endoscopy segment held the largest market share in 2021. However, the drug delivery segment is estimated to register the highest CAGR during the forecast period.

CapsoVision, Inc.; Medtronic; Check-Cap; PENTAX Medical; Olympus Corporation; BodyCap; Otsuka America Pharmaceutical, Inc.; IntroMedic Co., Ltd; Jinshan Science & Technology.; and RF Co., Ltd are a few of the key companies operating in the smart pills market. These companies adopt product innovation strategies to meet evolving customer demands, which allows them to maintain their brand name. A few of the recent developments in the global smart pills market are mentioned below: